RJT
PROF

Raymond James Trust’s Profound Medical PROF Stock Holding History

Raymond James Trust’s Portfolio PROF Stock Details PROF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$95.5K Buy
12,000
+1,500
+14% +$13.6K ﹤0.01% 1288
2024
Q2 		$88.1K Buy
+10,500
New +$84.6K ﹤0.01% 1231

Other funds holding PROF

Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
LBA
Letko, Brosseau & Associates Montreal, Quebec, Canada $6.2B AUM 38.92% 1-Year Est. Return
RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
TIM
Timelo Investment Management Aurora, Ontario, Canada $127M AUM 23.73% 1-Year Est. Return
GA
Gagnon Advisors New York $136M AUM 21.55% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return

Raymond James Trust's PROF Position: Q3 2024 in Review

Raymond James Trust increased its Profound Medical (PROF) stake by 14% in Q3 2024, buying an estimated $13.6K and bringing the position to 12,000 shares worth $95.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1288.

Raymond James Trust first reported a position in PROF in Q2 2024 and has held it in 2 quarters since. 44 funds tracked by Wall St. Rank hold PROF as of Q3 2024.

  • Raymond James Trust held 12,000 shares of Profound Medical worth $95.5K as of Q3 2024.
  • Raymond James Trust bought 1,500 Profound Medical shares in Q3 2024, an estimated $13.6K.
  • Profound Medical made up ﹤0.01% of Raymond James Trust's portfolio in Q3 2024, its #1288 holding.
  • Raymond James Trust first reported a position in Profound Medical in Q2 2024 and has held it in 2 quarters since.
  • 44 funds tracked by Wall St. Rank held Profound Medical as of Q3 2024.

Based on Raymond James Trust's 13F filing for Q3 2024, filed 12 Nov 2024.